0 Evaluaciones
ID

15496

Descripción

Weekly Paclitaxel and Trastuzumab in Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01423695

Link

https://clinicaltrials.gov/show/NCT01423695

Palabras clave

Versiones (1)
  1. 1/6/16 1/6/16 -
Subido en

1 de junio de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

  • El más nuevo
  • Más antiguo
  • Popular
  • El más nuevo
    • El más nuevo
    • Más antiguo
    • Popular

    Sin comentarios

    Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

    Eligibility Metastatic Breast Cancer NCT01423695

    Inglés

    Eligibility Metastatic Breast Cancer NCT01423695

    1 formularios  
    Inclusion Criteria
    Descripción

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693
    histologically confirmed metastatic breast cancer overexpressing her2
    Descripción

    metastatic breast cancer

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1,1]
    C1960398
    UMLS CUI [1,2]
    C0027627
    pretreatment with anthracycline in either the adjuvant or palliative setting.
    Descripción

    anthracycline

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C0003234
    her2 positivity was defined as 2+ or 3+ overexpression using the dako herceptest, confirmed by fluorescence in-situ hybridization (fish) if 2+.
    Descripción

    her2 positivity

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C4031572
    informed consent
    Descripción

    informed consent

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C0021430
    Exclusion Criteria
    Descripción

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251
    more than 1 chemotherapy for advanced disease
    Descripción

    chemotherapy

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C0392920
    taxane or trastuzumab pretreatment
    Descripción

    taxane or trastuzumab

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C0215136
    UMLS CUI [2]
    C0728747
    brain metastases
    Descripción

    brain metastases

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C0220650
    eastern cooperative oncology group (ecog) performance status >1
    Descripción

    performance status

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C1520224
    pregnancy or lactation, childbearing potential without reliable contraception
    Descripción

    pregnancy or lactation

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C0032961
    UMLS CUI [2]
    C0006147
    clinically significant cardiac disease,
    Descripción

    cardiac disease

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C0018799
    neutrophils <1500/µl, platelets <75,000/µl
    Descripción

    neutrophils platelets

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C0948762
    UMLS CUI [2]
    C0005821
    total bilirubin and creatinine >1.5 × the upper limit of normal
    Descripción

    total bilirubin and creatinine

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C0201913
    UMLS CUI [2]
    C0201976
    Volver a la parte superior de la página

    Similar models

    Eligibility Metastatic Breast Cancer NCT01423695

    1 formularios
    Name
    Tipo
    Description | Question | Decode (Coded Value)
    Tipo de datos
    Alias
    Item Group
    C1512693 (UMLS CUI)
    metastatic breast cancer
    Item
    histologically confirmed metastatic breast cancer overexpressing her2
    boolean
    C1960398 (UMLS CUI [1,1])
    C0027627 (UMLS CUI [1,2])
    anthracycline
    Item
    pretreatment with anthracycline in either the adjuvant or palliative setting.
    boolean
    C0003234 (UMLS CUI [1])
    her2 positivity
    Item
    her2 positivity was defined as 2+ or 3+ overexpression using the dako herceptest, confirmed by fluorescence in-situ hybridization (fish) if 2+.
    boolean
    C4031572 (UMLS CUI [1])
    informed consent
    Item
    informed consent
    boolean
    C0021430 (UMLS CUI [1])
    Item Group
    C0680251 (UMLS CUI)
    chemotherapy
    Item
    more than 1 chemotherapy for advanced disease
    boolean
    C0392920 (UMLS CUI [1])
    taxane or trastuzumab
    Item
    taxane or trastuzumab pretreatment
    boolean
    C0215136 (UMLS CUI [1])
    C0728747 (UMLS CUI [2])
    brain metastases
    Item
    brain metastases
    boolean
    C0220650 (UMLS CUI [1])
    performance status
    Item
    eastern cooperative oncology group (ecog) performance status >1
    boolean
    C1520224 (UMLS CUI [1])
    pregnancy or lactation
    Item
    pregnancy or lactation, childbearing potential without reliable contraception
    boolean
    C0032961 (UMLS CUI [1])
    C0006147 (UMLS CUI [2])
    cardiac disease
    Item
    clinically significant cardiac disease,
    boolean
    C0018799 (UMLS CUI [1])
    neutrophils platelets
    Item
    neutrophils <1500/µl, platelets <75,000/µl
    boolean
    C0948762 (UMLS CUI [1])
    C0005821 (UMLS CUI [2])
    total bilirubin and creatinine
    Item
    total bilirubin and creatinine >1.5 × the upper limit of normal
    boolean
    C0201913 (UMLS CUI [1])
    C0201976 (UMLS CUI [2])
    Volver a la parte superior de la página 

    Ayuda

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial